Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Digestive System Carcinoma”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Testing effectiveness (Phase 2)UnknownNCT05007145
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 92
Testing effectiveness (Phase 2)Looking for participantsNCT06397222
What this trial is testing

Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 23
Not applicableActive Not RecruitingNCT04560712
What this trial is testing

Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery

Who this might be right for
Resectable Colorectal CarcinomaResectable Digestive System CarcinomaResectable Pancreatic Carcinoma
M.D. Anderson Cancer Center 70
Not applicableUnknownNCT01891539
What this trial is testing

Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma

Who this might be right for
Liver Cell Carcinoma Non-resectable
International Group of Endovascular Oncology 100
Testing effectiveness (Phase 2)Study completedNCT00005629
What this trial is testing

Vaccine Therapy in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT05182944
What this trial is testing

Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 130
Testing effectiveness (Phase 2)UnknownNCT04819971
What this trial is testing

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

Who this might be right for
Stomach Cancer
The First Affiliated Hospital of Zhengzhou University 67
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07012798
What this trial is testing

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Not applicableLooking for participantsNCT05713994
What this trial is testing

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD 300
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)UnknownNCT04930315
What this trial is testing

SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT02676349
What this trial is testing

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Who this might be right for
Pancreatic Carcinoma
Institut de Cancérologie de Lorraine 130
Testing effectiveness (Phase 2)Study completedNCT00319735
What this trial is testing

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Who this might be right for
Esophageal Cancer
Nasser Hanna, M.D. 41
Testing effectiveness (Phase 2)Study completedNCT01395030
What this trial is testing

PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection

Who this might be right for
Adult Hepatocellular CarcinomaLocalized Resectable Adult Liver Carcinoma
Queen's Medical Center 64
Not applicableLooking for participantsNCT04796818
What this trial is testing

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+4 more
M.D. Anderson Cancer Center 70
Large-scale testing (Phase 3)Looking for participantsNCT05608213
What this trial is testing

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 187
Testing effectiveness (Phase 2)Study completedNCT01624285
What this trial is testing

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
Jonsson Comprehensive Cancer Center 20
Not applicableUnknownNCT05621499
What this trial is testing

HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)UnknownNCT03603834
What this trial is testing

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Khon Kaen University 25
Load More Results